Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
Status:
Not yet recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy and safety of IV FCM(ferric
carboxymaltose) in patients with AGC receiving palliative chemotherapy. This study will also
evaluate the effect of IV FCM on the treatment outcomes of palliative chemotherapy in
patients with gastric cancer receiving fluoropyrimidine and platinum-based regimen in the
same 1st-line palliative setting.